title: Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
abstract: BACKGROUND
  One of the most common genetic aberrations associated with breast cancer is the amplification and overexpression of the ERBB2 proto-oncogene located at chromosome 17, bands q12-21. The amplification/overexpression occurs in 25 to 30% of all breast cancers. In breast cancer, aneusomy of chromosome 17, either monosomy or polysomy, is frequently observed by conventional cytogenetics and fluorescence in situ hybridization (FISH). The aim of this study was to discover whether or not numerical aberrations on chromosome 17 have a correlation to the amplification or overexpression of the ERBB2 gene and to analyze their clinical implications in subgroups showing 2+ or 3+ positive scores by immunohistochemistry (IHC).
  
  
  METHODS
  We used FISH on a series of 175 formalin-fixed paraffin-embedded breast carcinomas to detect ERBB2 amplification, using a dual-probe system for the simultaneous enumeration of the ERBB2 gene and the centromeric region of chromosome 17, as well as using IHC to detect overexpression. We analyzed clinical and pathological variables in a subgroup of patients with 2+ and 3+ IHC scores (147 patients), to describe any differences in clinicopathological characteristics between polysomic and non-polysomic cases with the use of the chi2 test.
  
  
  RESULTS
  We found 13% of cases presenting polysomy, and three cases presented monosomy 17 (2%). According to the status of the ERBB2 gene, instances of polysomy 17 were more frequently observed in non-amplified cases than in FISH-amplified cases, suggesting that the mechanism for ERBB2 amplification is independent of polysomy 17. Polysomy 17 was detected in patients with 2+ and 3+ IHC scores. We found that nodal involvement was more frequent in polysomic than in non-polysomic cases (P = 0.046).
  
  
  CONCLUSIONS
  The determination of the copy number of chromosome 17 should be incorporated into the assesment of ERBB2 status. It might also be helpful to differentiate a subgroup of breast cancer patients with polysomy of chromosome 17 and overexpression of ERBB2 protein that probably have genetic and clinical differences.
authors.affiliation: Laboratori de Citogenètica i Biologia Molecular, Servei de Patologia, Hospital del Mar, IMAS, Barcelona, Spain. MSALIDO@IMAS.IMIM.ES
authors.forename: Marta
authors.initials: M
authors.lastname: Salido
authors.forename: Ignasi
authors.initials: I
authors.lastname: Tusquets
authors.forename: Josep M
authors.initials: JM
authors.lastname: Corominas
authors.forename: Marta
authors.initials: M
authors.lastname: Suarez
authors.forename: Blanca
authors.initials: B
authors.lastname: Espinet
authors.forename: Cristina
authors.initials: C
authors.lastname: Corzo
authors.forename: Meritxell
authors.initials: M
authors.lastname: Bellet
authors.forename: Xavier
authors.initials: X
authors.lastname: Fabregat
authors.forename: Sergi
authors.initials: S
authors.lastname: Serrano
authors.forename: Francesc
authors.initials: F
authors.lastname: Solé
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D002869:Chromosome Aberrations; D002887:Chromosomes, Human, Pair 18; D005260:Female; D005784:Gene Amplification; D018628:Gene Dosage; D020869:Gene Expression Profiling; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D011446:Prospective Studies; D000090063:Proto-Oncogene Mas; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis* / Q000235:genetics; D015854:Up-Regulation
chemical_list: D000090063:Proto-Oncogene Mas; D018719:Erb-b2 Receptor Tyrosine Kinases; C000715470:MAS1 protein, human
references.citation: J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):109-17
references.pmid: 10882297
references.citation: APMIS. 1998 Oct;106(10):921-7
references.pmid: 9833692
references.citation: Semin Oncol. 2000 Dec;27(6 Suppl 11):38-45; discussion 92-100
references.pmid: 11236027
references.citation: Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
references.pmid: 11252954
references.citation: Cancer. 2001 Apr 25;93(2):165-70
references.pmid: 11309784
references.citation: J Clin Oncol. 2001 May 15;19(10):2714-21
references.pmid: 11352964
references.citation: J Clin Oncol. 1999 Sep;17(9):2639-48
references.pmid: 10561337
references.citation: Mayo Clin Proc. 2002 Feb;77(2):148-54
references.pmid: 11838648
references.citation: Mod Pathol. 2002 Feb;15(2):137-45
references.pmid: 11850542
references.citation: Breast J. 2001 Sep-Oct;7(5):337-44
references.pmid: 11906444
references.citation: Am J Clin Pathol. 2002 Jun;117(6):935-43
references.pmid: 12047146
references.citation: Breast Cancer Res Treat. 2003 Jan;77(2):109-14
references.pmid: 12602909
references.citation: J Mol Diagn. 2003 Aug;5(3):155-9
references.pmid: 12876205
references.citation: Am J Clin Pathol. 2004 Jan;121(1):70-7
references.pmid: 14750243
references.citation: Science. 1985 Dec 6;230(4730):1132-9
references.pmid: 2999974
references.citation: Science. 1986 Jun 27;232(4758):1644-6
references.pmid: 3012781
references.citation: Science. 1987 Jan 9;235(4785):177-82
references.pmid: 3798106
references.citation: Genomics. 1989 Apr;4(3):362-6
references.pmid: 2565881
references.citation: Science. 1989 May 12;244(4905):707-12
references.pmid: 2470152
references.citation: J Clin Oncol. 1992 Jul;10(7):1049-56
references.pmid: 1351538
references.citation: Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5321-5
references.pmid: 1351679
references.citation: Biochim Biophys Acta. 1993 May 25;1155(1):25-41
references.pmid: 8504129
references.citation: Cancer Res. 1993 Oct 15;53(20):4960-70
references.pmid: 8104689
references.citation: Cancer Res. 1994 May 15;54(10):2771-7
references.pmid: 7909495
references.citation: Genes Chromosomes Cancer. 1995 Mar;12(3):173-85
references.pmid: 7536456
references.citation: J Clin Oncol. 1996 Mar;14(3):737-44
references.pmid: 8622019
references.citation: Oncogene. 1996 Jul 4;13(1):63-72
references.pmid: 8700555
references.citation: Stem Cells. 1997;15(1):1-8
references.pmid: 9007217
references.citation: FEBS Lett. 1997 Jun 23;410(1):83-6
references.pmid: 9247128
references.citation: J Clin Oncol. 1998 Apr;16(4):1340-9
references.pmid: 9552035
references.citation: Cancer Res. 1998 Jul 1;58(13):2825-31
references.pmid: 9661897
references.citation: Oncogene. 1998 Oct 29;17(17):2235-49
references.pmid: 9811454
references.citation: J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):143-51
references.pmid: 10882300